Spacer
Spacer
SEARCH
Spacer
Spacer
Quotes News NAV
Spacer
Spacer
Spacer
Spacer
Spacer
Profit & Loss Markets  >  Corporate Information  >   Profit & Loss
Spacer
Glenmark Pharmaceuticals Ltd Industry:  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code ISIN Demat Book Value
(R)
NSE
Symbol
Div Yield
%
Market Cap
(Rs.Cr)
P/E
(TTM)
EPS
(TTM)
Face Value
(R)
532296 INE935A01035 855.7128074 GLENMARK 0.2 69,145.04 47.36 51.73 1
Your Result on : Markets | Equity | Corporate Information | Profit & Loss
     ParticularsMar 2026
(Rs.Cr)
Mar 2025
(Rs.Cr)
Mar 2024
(Rs.Cr)
Mar 2023
(Rs.Cr)
Mar 2022
(Rs.Cr)
Mar 2021
(Rs.Cr)
INCOME :      
Sales Turnover 8440.109226.417891.128220.668141.587567.93
Excise Duty0.000.000.000.000.000.00
Net Sales8440.109226.417891.128220.668141.587567.93
Other Income 772.02356.376238.36985.941044.96470.13
Stock Adjustments 105.42-44.48103.0731.3716.13-5.24
Total Income9317.549538.3014232.559237.979202.678032.82
EXPENDITURE :      
Raw Materials 3184.373154.653313.193427.073425.062944.53
Power & Fuel Cost112.65114.62104.9295.0991.3480.49
Employee Cost 1790.411603.501434.781346.511193.201107.40
Other Manufacturing Expenses 370.83372.36375.32304.66347.04267.26
Selling & Administrative Expenses 1593.611305.301199.171246.101062.89914.37
Miscellaneous Expenses 2217.11566.49325.15855.71349.97358.30
Less : Pre-operative Expenses Capitalised 0.000.000.000.000.000.00
Total Expenditure9268.977116.926752.527275.136469.505672.35
Operating Profit48.572421.387480.021962.842733.182360.47
Interest 78.7548.73277.11206.82236.04265.90
Gross Profit-30.182372.657202.911756.022497.142094.57
Depreciation235.89218.63202.16184.15159.70150.82
Profit Before Tax-266.072154.027000.751571.872337.441943.75
Tax-724.52600.761049.99386.93411.08343.62
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax659.25-57.09783.46-23.83-71.42-49.31
Reported Net Profit-200.801610.355167.291208.771997.791649.45
Extraordinary Items -1143.27-152.913742.26-369.56354.0259.87
Adjusted Net Profit942.471763.261425.031578.331643.771589.58
Adjustment below Net Profit -16.96-6.47-4.760.631.612.48
P & L Balance brought forward22581.1521088.1316002.8214863.9612921.8611340.47
Statutory Appropriations0.000.000.000.000.000.00
Appropriations 266.25110.8777.2270.5457.3070.54
P & L Balance carried down22097.1522581.1521088.1316002.8214863.9612921.86
Dividend0.000.000.000.000.000.00
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %500.00250.00250.00250.00250.00250.00
Dividend Per Share(Rs)5.002.502.502.502.502.50
Earnings Per Share-Unit Curr-7.1257.07183.1142.8470.8058.46
Earnings Per Share(Adj)-Unit Curr-7.1257.07183.1142.8470.8058.46
Book Value-Unit Curr855.79868.35814.01633.57593.21524.84
Book Value(Adj)-Unit Curr855.79868.35814.01633.57593.21524.84
Spacer